Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

MPTP

  • Articles, Neurobiology of Disease
    Dopamine Replacement Therapy Does Not Restore the Full Spectrum of Normal Pallidal Activity in the 1-Methyl-4-Phenyl-1,2,3,6-Tetra-Hydropyridine Primate Model of Parkinsonism
    Gali Heimer, Michal Rivlin-Etzion, Izhar Bar-Gad, Joshua A. Goldberg, Suzanne N. Haber and Hagai Bergman
    Journal of Neuroscience 2 August 2006, 26 (31) 8101-8114; https://doi.org/10.1523/JNEUROSCI.5140-05.2006
  • Behavioral/Systems/Cognitive
    3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates
    Mahmoud M. Iravani, Michael J. Jackson, Mikko Kuoppamäki, Lance A. Smith and Peter Jenner
    Journal of Neuroscience 8 October 2003, 23 (27) 9107-9115; https://doi.org/10.1523/JNEUROSCI.23-27-09107.2003
  • Behavioral/Systems/Cognitive
    Chromosomal Loci Influencing the Susceptibility to the Parkinsonian Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
    Marco Sedelis, Katja Hofele, Rainer K. W. Schwarting, Joseph P. Huston and John K. Belknap
    Journal of Neuroscience 10 September 2003, 23 (23) 8247-8253; https://doi.org/10.1523/JNEUROSCI.23-23-08247.2003
  • ARTICLE, Behavioral/Systems/Cognitive
    Stimulation of the Subthalamic Nucleus Changes the Firing Pattern of Pallidal Neurons
    Takao Hashimoto, Christopher M. Elder, Michael S. Okun, Susan K. Patrick and Jerrold L. Vitek
    Journal of Neuroscience 1 March 2003, 23 (5) 1916-1923; https://doi.org/10.1523/JNEUROSCI.23-05-01916.2003
  • ARTICLE, Cellular/Molecular
    Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
    Du Chu Wu, Vernice Jackson-Lewis, Miquel Vila, Kim Tieu, Peter Teismann, Caryn Vadseth, Dong-Kug Choi, Harry Ischiropoulos and Serge Przedborski
    Journal of Neuroscience 1 March 2002, 22 (5) 1763-1771; https://doi.org/10.1523/JNEUROSCI.22-05-01763.2002
  • ARTICLE, Cellular/Molecular
    Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease
    Veena Viswanath, Yongqin Wu, Rapee Boonplueang, Sylvia Chen, Fang Feng Stevenson, Ferda Yantiri, Lichuan Yang, M. Flint Beal and Julie K. Andersen
    Journal of Neuroscience 15 December 2001, 21 (24) 9519-9528; https://doi.org/10.1523/JNEUROSCI.21-24-09519.2001
  • ARTICLE, Cellular/Molecular
    Vulnerability of 125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
    Maryka Quik, Yelena Polonskaya, Jennifer M. Kulak and J. Michael McIntosh
    Journal of Neuroscience 1 August 2001, 21 (15) 5494-5500; https://doi.org/10.1523/JNEUROSCI.21-15-05494.2001
  • ARTICLE, Behavioral/Systems
    Expression of Striatal Preprotachykinin mRNA in Symptomatic and Asymptomatic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Exposed Monkeys Is Related to Parkinsonian Motor Signs
    Timothy V. Wade and Jay S. Schneider
    Journal of Neuroscience 1 July 2001, 21 (13) 4901-4907; https://doi.org/10.1523/JNEUROSCI.21-13-04901.2001
  • ARTICLE, Cellular/Molecular
    Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis
    Andreas Hartmann, Jean-Denis Troadec, Stéphane Hunot, Kristy Kikly, Baptiste A. Faucheux, Annick Mouatt-Prigent, Merle Ruberg, Yves Agid and Etienne C. Hirsch
    Journal of Neuroscience 1 April 2001, 21 (7) 2247-2255; https://doi.org/10.1523/JNEUROSCI.21-07-02247.2001
  • ARTICLE, Behavioral/Systems
    Firing Patterns and Correlations of Spontaneous Discharge of Pallidal Neurons in the Normal and the Tremulous 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Vervet Model of Parkinsonism
    Aeyal Raz, Eilon Vaadia and Hagai Bergman
    Journal of Neuroscience 15 November 2000, 20 (22) 8559-8571; https://doi.org/10.1523/JNEUROSCI.20-22-08559.2000

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.